Tartaric Acid
Medchemexpress LLC DL-tartaric acid (anhydrous) | 133-37-9 | MFCD00071626 | 98.0% | 10g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Medchemexpress LLC D-(-)-tartaric acid | 147-71-7 | MFCD00004238 | 150.09 g/mol | C4H6O6 | 10g
D-Tartaric acid (D-(-)-Tartaric acid) is a polyhydroxy acid D-Tartaric acid crystal structure is studied by X-ray and neutron diffraction[1][2]
Pfaltz & Bauer meso-Tartaric Acid Hydrate 98 5G | 5990-63-6
meso-Tartaric Acid Hydrate 98 5G | 5990-63-6
Apexbio Technology LLC ENMD-2076 L-(+)-Tartaric acid 1291074-87-7 5mg
ENMD-2076 L- plus -Tartaric acid is a small-molecule inhibitor targeting Aurora kinase A and B It is designed to inhibit the activity of these kinases thereby regulating cell cycle progression and mitotic processes ENMD-2076 L- plus -Tartaric acid exerts its biological activity primarily through the inhibition of Aurora kinase A and B with IC50 values of approximately 14 nM and 350 nM respectively In cell-based studies ENMD-2076 inhibits various breast cancer cell lines suppresses colony formation and induces G2 phase cell-cycle arrest Based on these pharmacological properties ENMD-2076 L- plus -Tartaric acid holds research potential in breast and hematological malignancies
TARGETMOL CHEMICALS INC ENMD-2076 5MG
Also available in 1 mL, 1 mg, 2 mg, 10 mg, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. ENMD-2076, a multi-targeted kinase inhibitor, has specific activity against Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, PDGFRalpha. Purity 98%
Apexbio Technology LLC ENMD-2076 934353-76-1 10mg
ENMD-2076 (CAS 934353-76-1) is a selective inhibitor of Aurora A kinase (IC50 14 nM) and FLT3 (IC50 1 86 nM) with additional inhibitory activity against multiple tyrosine kinases implicated in angiogenesis and cell proliferation including RET FLT4/VEGFR3 SRC CSF1R NTRK1 FGFR1/2 VEGFR2/KDR LCK and PDGFR (IC50 1 86 120 nM) ENMD-2076 disrupts cell cycle progression by arresting cells in the G2/M phase through inhibition of Aurora kinases suppresses the PI3K/AKT signaling pathway and demonstrates cytotoxic effects in hematologic malignancy and solid tumor cell lines (in vitro IC50 25 700 nM) In vivo it reduces tumor growth and angiogenesis in xenograft models supporting its use in cancer research and antiangiogenic studies
Selleck Chemical LLC L-Tartaric acid
L-Tartaric acid (2 3-Dihydroxysuccinic acid Threaric acid Racemic acid Uvic acid Paratartaric acid Winestone) is a white crystalline organic acid that occurs naturally in many plants most notably in grapes It has several applications for industrial and pharmaceutical use
Apexbio Technology LLC ENMD-2076 L-(+)-Tartaric acid 1291074-87-7 50mg
ENMD-2076 L- plus -Tartaric acid is a small-molecule inhibitor targeting Aurora kinase A and B It is designed to inhibit the activity of these kinases thereby regulating cell cycle progression and mitotic processes ENMD-2076 L- plus -Tartaric acid exerts its biological activity primarily through the inhibition of Aurora kinase A and B with IC50 values of approximately 14 nM and 350 nM respectively In cell-based studies ENMD-2076 inhibits various breast cancer cell lines suppresses colony formation and induces G2 phase cell-cycle arrest Based on these pharmacological properties ENMD-2076 L- plus -Tartaric acid holds research potential in breast and hematological malignancies
c1ccc(C)cc1)C(O)=O)C(O)=O | 5g | 552687867](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502427267.PNG-250.jpg)
eMolecules 32634-68-7 | Di-p-toluoyl-D-tartaric Acid | Ambeed | MFCD00008552 | 386.356 | C20H18O8 | 98.000 | Cc1ccc(cc1)C(=O)O[C@@H]([C@H](OC(=O)c1ccc(C)cc1)C(O)=O)C(O)=O | 5g | 552687867
Di-p-toluoyl-D-tartaric Acid | Ambeed | 32634-68-7 | MFCD00008552 | 386.356 | C20H18O8 | 98.000 | Cc1ccc(cc1)C(=O)O[C@@H]([C@H](OC(=O)c1ccc(C)cc1)C(O)=O)C(O)=O | 5g | 552687867
Medchemexpress LLC Fosphenytoin disodium | 92134-98-0 | 99.9% | 50 MG
Fosphenytoin sodium is a proagent of phenytoin with similar anticonvulsant properties. Its primary mechanism of action involves blocking frequency-dependent, use-dependent, and voltage-dependent neuronal sodium channels, thereby limiting the repetitive firing of action potentials.
- Effective neuroprotectant against ischemia-induced damage.
- Dose-dependently increases the focal seizure (afterdischarge) threshold in kindled rats.
- Reduces seizure severity and duration at higher doses in kindled rats.
Medchemexpress LLC Tartaric acid disodium dihydrate | 6106-24-7 | 98.0% | 50 G
Tartaric acid disodium dihydrate, also known as L-(+)-tartaric acid, is a weak organic acid derived from grapes. It is orally active and demonstrates vasodilatory and antihypertensive properties. This compound serves various applications, including its use as a flavoring and antioxidant in the food and beverage industry, as well as in laser frequency doubling and optical limiting technologies.
- Orally active weak organic acid
- Isolated from grapes
- Exhibits vasodilatory effects
- Shows antihypertensive effects
- Used as flavoring in foods and beverages
- Functions as an antioxidant in foods and beverages
- Applied in laser frequency doubling
- Used in optical limiting applications
- Reduces NEP and KCL-induced aortic ring vasoconstriction
- Reduces blood pressure in hypertensive mice
Medchemexpress LLC Tartaric acid disodium dihydrate | 6106-24-7 | 98.0% | 1 ML
Tartaric acid disodium dihydrate is an orally active weak organic acid that can be isolated from grapes. It has vasodilatory and antihypertensive effects. It can be used as flavorings and antioxidants in a range of foods and beverages, and also in laser frequency doubling and optical limiting applications.
- Orally active weak organic acid
- Can be isolated from grapes
- Has vasodilatory and antihypertensive effects
- Can be used as flavorings and antioxidants in food and beverages
- Can be used in laser frequency doubling and optical limiting applications